Prostatic sarcoma of the Ewing family in a 33-year-old male——A case report and review of the literature

doi:10.1016/j.ajur.2015.11.007

Asian Journal of Urology, 2016, 3 (2): 103-106 doi: 10.1016/j.ajur.2015.11.007

Case Report

Current Issue | Archive | Adv Search

Prostatic sarcoma of the Ewing family in a 33-year-old male——A case report and review of the literature

Lukas Esch^a, Dimitri Barski^a, Reinhold Bug^b, Thomas Otto^a

a Department of Urology, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany;
b Department of Pathology, Städtische Kliniken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany

Abstract
Related Citation (15)

Download:

HTML

PDF (1251KB)
Export: BibTeX | EndNote (RIS)

Abstract Ewing sarcoma is the second most common primary bone tumor seen in children and adolescents, typically presenting between 10 and 20 years of age. Extraosseous sarcomas of the Ewing family in adults are rare. We report a manifestation of this tumor entity in the periprostatic tissue of a 33-year-old male and discuss our treatment approach. Transrectal biopsy is a feasible and simple diagnostic tool for unclear pelvic masses. Multi-modal therapy and central registries are needed to gain knowledge of rare pelvic tumors like Ewing sarcoma.

Key words： Ewing sarcoma Pelvic neoplasms Adult Surgery Chemotherapy Prostate

Received: 26 August 2015 Published: 13 May 2016

Corresponding Authors: Dimitri Barski E-mail: dbarski@lukasneuss.de

	Service
	E-mail this article
	Add to citation manager
	E-mail Alert
	Articles by authors
	Lukas Esch
	Dimitri Barski
	Reinhold Bug
	Thomas Otto

TRENDMD:

Cite this article:

Lukas Esch,Dimitri Barski,Reinhold Bug, et al. Prostatic sarcoma of the Ewing family in a 33-year-old male——A case report and review of the literature[J]. Asian Journal of Urology, 2016, 3(2): 103-106.

URL:

http://www.ajurology.com/EN/10.1016/j.ajur.2015.11.007 OR http://www.ajurology.com/EN/Y2016/V3/I2/103

[1]	Chen QR, Vansant G, Oades K, Pickering M, Wei JS, Song YK, et al. Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction. J Mol Diagn 2007;9:80-8.
[2]	Rajwanshi A, Srinivas R, Upasana G. Malignant small round cell tumors. J Cytol 2008;26:1-10.
[3]	Thway K. Primitive round cell neoplasms. Surg Pathol Clin 2010;4:799-818.
[4]	Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, et al. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-9.
[5]	Gu M, Antonescu CR, Guiter G, Huvos AG, Ladanyi M, Zakowski MF. Cytokeratin immunoreactivity in Ewing's sarcoma:prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol 2000;24:410-6.
[6]	Iwamoto Y. Diagnosis and treatment of Ewing's sarcoma. Jpn J Clin Oncol 2007;37:79-89.
[7]	Postel-Vinay S, Véron AS, Tirode F, Pierron G, Reynaud S, Kovar H, et al. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 2012;44:323-7.
[8]	Applebaum MA, Worch J, Matthay KK, Goldsby R, Neuhaus J, West DC. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer 2011;117:3027-32.
[9]	Eyre R, Feltbower RG, James PW, Blakey K, Mubwandarikwa E, Forman D, et al. The epidemiology of bone cancer in 0-39 year olds in northern England, 1981-2002. BMC Cancer 2010; 10:357.
[10]	Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome. Cancer 2009;115:3526-36.
[11]	Esiashvili N, Goodman M, Marcus RB. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades. J Pediatr Hematol Oncol 2008;30:425-30.
[12]	Eyre R, Feltbower RG, Mubwandarikwa E, Eden TOB, McNally RJQ. Epidemiology of bone tumours in children and young adults. Pediatr Blood Cancer 2009;53:941-52.
[13]	Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJH, Pritchard DJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701.
[14]	Donaldson SS, Torrey M, Link MP, Glicksman A, Gilula L, Laurie F, et al. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma:end results of POG #8346. Int J Radiat Oncol Biol Phys 1998;42:125-35.
[15]	Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, et al. Local control in pelvic Ewing sarcoma:analysis from INT-0091ea report from the Children's Oncology Group. J Clin Oncol 2006;24:3838-43.
[16]	Marcus R, Hagenbeek A. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Eur J Haematol Suppl 2007;78:5-14.
[17]	El Weshi A, Allam A, Ajarim D, Al Dayel F, Pant R, Bazarbashi S, et al. Extraskeletal Ewing's sarcoma family of tumours in adults:analysis of 57 patients from a single institution. Clin Oncol R Coll Radiol 2010;22:374-81.
[18]	Raney RB, Asmar L, Newton Jr WA, Bagwell C, Breneman JC, Crist W, et al. Ewing's sarcoma of soft tissues in childhood:a report from the intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol 1997;15:574-82.
[19]	Ellinger J, Bastian PJ, Hauser S, Biermann K, Müller SC. Primitive neuroectodermal tumor:rare, highly aggressive differential diagnosis in urologic malignancies. Urology 2006; 68:257-62.
[20]	Okada Y, Kamata S, Akashi T, Kurata M, Nakamura T, Kihara K. Primitive neuroectodermal tumor/Ewing's sarcoma of the urinary bladder:a case report and its molecular diagnosis. Int J Clin Oncol 2011;16:435-8.
[21]	Zhang DW, Jin M, Zhou CJ, Song HC, Ma XL.[Primitive neuroectodermal tumor/Ewing's sarcoma of the penis in children:a case report and review of the literature]. Zhonghua Nan Ke Xue 2012;18:1115-8[Article in Chinese].
[22]	Tsang YP, Lang BH, Tam SC, Wong KP. Primitive neuroectodermal adrenal gland tumour. Hong Kong Med J 2014;20:444-6.
[23]	Colecchia M, Dagrada GP, Poliani PL, Messina A, Pilotti S. Primary primitive peripheral neuroectodermal tumor of the prostate. Immunophenotypic and molecular study of a case. Arch Pathol 2003;127:e190-3.
[24]	Peyromaure M, Vieillefond A, Boucher E, de Pinieux G, Beuzeboc P, Debré B, et al. Primitive neuroectodermal tumor of the prostate. J Urol 2003;170:182-3.
[25]	Thete N, Rastogi D, Arya S, Singh A, Rao P, Chandge A, et al. Primitive neuroectodermal tumour of the prostate gland:ultrasound and MRI findings. Br J Radiol 2007;80:e180-3.
[26]	Kumar V, Khurana N, Rathi AK, Malhotra A, Sharma K, Abhishek A, et al. Primitive neuroectodermal tumor of prostate. Indian J Pathol Microbiol 2008;51:386-8.
[27]	Funahashi Y, Yoshino Y, Hattori R. Ewing's sarcoma/primitive neuroectodermal tumor of the prostate. Int J Urol 2009;16:769.
[28]	Mohsin R, Hashmi A, Mubarak M, Sultan G, Shehzad A, Qayum A, et al. Primitive neuroectodermal tumor/Ewing's sarcoma in adult uro-oncology:a case series from a developing country. Urol Ann 2011;3:103-7.
[29]	Al Haddabi I, Al Bahri M, Burney I. Cytokeratin-positive primitive neuroectodermal tumor of the prostate:case report and review of literature. Indian J Pathol Microbiol 2012;55:569-71.
[30]	Wu T, Jin T, Luo D, Chen L, Li X. Ewing's sarcoma/primitive neuroectodermal tumour of the prostate a case report and literature review. Can Urol Assoc J 2013;7:458-9.
[31]	Shibuya T, Mori K, Sumino Y, Sato F, Mimata H. Rapidly progressive primitive neuroectodermal tumor of the prostate:a case report and review of the literature. Oncol Lett 2015;9:634-6.